Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Neuroimaging and CSF Biomarkers

    Neuroimaging and CSF Biomarkers supports researchers and clinicians developing and validating biomarkers to advance drug development, diagnosis, and monitoring for Alzheimer's disease and related dementias.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Drug Development RFP

    Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.

    Alzheimers Drug DiscoveryDue Dec 7, 2026· 21d$5,000,000

    Digital Biomarker Development Program

    Funds research to develop, validate, and translate digital biomarkers (e.g., wearables, apps, sensors) for Alzheimer's disease detection and monitoring.

    Alzheimers Drug DiscoveryForecasted Feb 1, 2027$500,000Forecasted

    Accelerating Drug Discovery for Frontotemporal Degeneration

    Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.

    Alzheimers Drug DiscoveryForecasted Mar 15, 2027$300,000Forecasted

    Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

    Funding for developing biomarkers to aid in clinical development of neurotherapeutics for neurological and neuromuscular disorders.

    HHS-NIH11Due Feb 22, 2027

    Alzheimer’s Disease Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia - Understanding Mechanisms of Dysfunction (VCID-UMD)

    VCID-UMD supports collaborating researchers studying vascular dysfunction and its links to immune, lipid and endolysosomal functions to understand its contributions to Alzheimer’s and related dementias.

    Alzheimers AssociationForecasted Jun 15, 2027$300,000Forecasted